MANF orphan Dry Age-related Macular Degeneration - my hypothesis for Monday's announcement

-NeuroAssets is doing MANF research in ocular orphans
-Dr. Roman Urfer, Chief Development Officer at NeuroAssets Sarl is presenting
-if it was Wolfram's-related ocular disorder, then I would think that Dr. Urano would be involved in the presentation
-GC specifically points out Dry-AMD

Quote:

---

We believe RP is just the beginning of the MANF story in ophthalmology. Other neurotrophic factors have begun to show promise in many diseases in the area and the data announced earlier this week scientifically supports development in many therapeutic indications beyond RP in ophthalmology, including Dry Age-Related Macular Degeneration (Dry AMD) . Dry AMD affects approximately 15 million people in the United States. 14%-24% of the U.S. population age 65-74 years and 35% of people aged 75 years or older have the disease[1]. Currently, there are no available disease-modifying treatments for Dry AMD, making the opportunity for MANF so attractive. MANF’s development in RP may accelerate the pathway for it to reach the significantly larger Dry AMD patient population by proving cone and rod protection in humans in the smaller RP population first.

---

http://www.thechairmansblog.com/amarantus-bio...igmentosa/